Literature DB >> 31096240

Importance of Genetic Diagnostics in Adult-Onset Focal Segmental Glomerulosclerosis.

Rozemarijn Snoek1, Tri Q Nguyen2, Bert van der Zwaag1, Arjan D van Zuilen3, Hannah M E Kruis4, Liesbeth A van Gils-Verrij5, Roel Goldschmeding2, Nine V A M Knoers1,6, Maarten B Rookmaaker3, Albertien M van Eerde7.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is a histological pattern of podocyte and glomerulus injury. FSGS can be primary and secondary to other diseases or due to a genetic cause. Strikingly, genetic causes for adult-onset FSGS are often overlooked, likely because identifying patients with genetic forms of FSGS based on clinical presentation and histopathology is difficult. Yet diagnosing genetic FSGS does not only have implications for prognostication and therapy but also for family and family planning. In this case series, we present 3 adult patients who presented with advanced renal disease with the histological picture of FSGS and proved to have a genetic cause of the disease, namely, variants in INF2, COL4A4 and HNF1B, respectively. We show the possibilities of identifying genetic FSGS based on clinical clues of a positive family history, early age at onset of disease, and/or severe therapy-resistant disease. We discuss ways to select the method of genetic testing for individual patients. Finally, we examine how the judicious use of genetic investigations can obviate potential harmful diagnostic procedures and direct clinical decisions in patients and their relatives.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  COL4A4; Focal segmental glomerulosclerosis; Gene panel; Genetics; HNF1B; INF2; Kidney biopsy

Year:  2019        PMID: 31096240      PMCID: PMC6727320          DOI: 10.1159/000499937

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  55 in total

Review 1.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

2.  Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.

Authors:  Therese C Jungraithmayr; Katrin Hofer; Pierre Cochat; Gil Chernin; Gerard Cortina; Sonja Fargue; Paul Grimm; Tanja Knueppel; Andreas Kowarsch; Thomas Neuhaus; Philipp Pagel; Karl P Pfeiffer; Franz Schäfer; Ulf Schönermarck; Tomas Seeman; Burkhard Toenshoff; Stefanie Weber; Michelle P Winn; Johannes Zschocke; Lothar B Zimmerhackl
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

3.  Mutations in PAX2 associate with adult-onset FSGS.

Authors:  Moumita Barua; Emilia Stellacci; Lorenzo Stella; Astrid Weins; Giulio Genovese; Valentina Muto; Viviana Caputo; Hakan R Toka; Victoria T Charoonratana; Marco Tartaglia; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

Review 4.  Causes and pathogenesis of focal segmental glomerulosclerosis.

Authors:  Agnes B Fogo
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

5.  Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis.

Authors:  Olivia Boyer; Geneviève Benoit; Olivier Gribouval; Fabien Nevo; Marie-Josèphe Tête; Jacques Dantal; Brigitte Gilbert-Dussardier; Guy Touchard; Alexandre Karras; Claire Presne; Jean-Pierre Grunfeld; Christophe Legendre; Dominique Joly; Philippe Rieu; Nabil Mohsin; Thierry Hannedouche; Valérie Moal; Marie-Claire Gubler; Isabelle Broutin; Géraldine Mollet; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

6.  Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria.

Authors:  Cèlia Badenas; Manuel Praga; Bárbara Tazón; Laurence Heidet; Christelle Arrondel; Anna Armengol; Amado Andrés; Enrique Morales; Juan Antonio Camacho; Xose Lens; Sonia Dávila; Montse Milà; Corinne Antignac; Alejandro Darnell; Roser Torra
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

7.  Coordinate gene expression of the alpha3, alpha4, and alpha5 chains of collagen type IV. Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation.

Authors:  P S Thorner; K Zheng; R Kalluri; R Jacobs; B G Hudson
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

8.  Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.

Authors:  Moumita Barua; Elizabeth J Brown; Victoria T Charoonratana; Giulio Genovese; Hua Sun; Martin R Pollak
Journal:  Kidney Int       Date:  2012-09-26       Impact factor: 10.612

9.  Diagnosing FSGS without kidney biopsy - a novel INF2-mutation in a family with ESRD of unknown origin.

Authors:  Johannes Münch; Maik Grohmann; Tom H Lindner; Carsten Bergmann; Jan Halbritter
Journal:  BMC Med Genet       Date:  2016-10-12       Impact factor: 2.103

10.  Ethnic disparities in the prevalence of metabolic syndrome and its risk factors in the Suriname Health Study: a cross-sectional population study.

Authors:  Ingrid S K Krishnadath; Jerry R Toelsie; Albert Hofman; Vincent W V Jaddoe
Journal:  BMJ Open       Date:  2016-12-07       Impact factor: 2.692

View more
  3 in total

1.  Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.

Authors:  Justin Chun; Minxian Wang; Maris S Wilkins; Andrea U Knob; Ava Benjamin; Lihong Bu; Martin R Pollak
Journal:  Kidney Int Rep       Date:  2020-01-08

Review 2.  Formins in Human Disease.

Authors:  Leticia Labat-de-Hoz; Miguel A Alonso
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

3.  Framework From a Multidisciplinary Approach for Transitioning Variants of Unknown Significance From Clinical Genetic Testing in Kidney Disease to a Definitive Classification.

Authors:  Uyenlinh L Mirshahi; Ahana Bhan; Lotte E Tholen; Brian Fang; Guoli Chen; Bryn Moore; Adam Cook; Prince Mohan Anand; Kashyap Patel; Mary E Haas; Luca A Lotta; Peter Igarashi; Jeroen H F de Baaij; Silvia Ferrè; Joost G J Hoenderop; David J Carey; Alexander R Chang
Journal:  Kidney Int Rep       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.